Implantable Infusion Pump

Medicare covers implantable infusion pumps and associated services when used for conditions specified in CMS NCD Manual Chapter 1 Part 4 §280.14 and when pumps are used to deliver medications via intra-arterial, intrathecal, or epidural routes. Intrathecal ziconotide is only covered when the patient is intolerant of or refractory to other treatments (including systemic analgesics, adjunctive therapies, or intrathecal morphine); implantation is contraindicated for patients with drug hypersensitivity, active infection, insufficient body size, or unmanaged interactions with other implanted programmable devices.

"Implantable infusion pumps and associated services are covered when used for conditions listed in the CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter..."

Sign up to see full coverage criteria, indications, and limitations.